UnitedHealth under criminal probe for possible Medicare fraud, WSJ reports

Go back to UnitedHealth under criminal probe for possible Medicare fraud, WSJ reports

Raymond James Cuts Estimates on UnitedHealth Group (UNH), 'Needless to say we think these earnings are low-quality and non-recurring in nature'

May 16, 2025 5:03 AM EDT

Raymond James analyst John Ransom reiterated a Market Perform rating and {REMOVEPT} price target on UnitedHealth Group (NYSE: UNH)

The analyst comments "We are reiterating our Market Perform rating on UNH and taking a sharper pencil to our numbers as we are cutting our 2025 adj. EPS estimate to $20/share (down from $22), and our 2026 EPS estimate to $23/share (down from $25). In our analysis we rebased the 2024 EPS down to $23.97 to account for $4.0B ($3.70 of EPS) of one-time accounting gains that UNH booked as earnings in 2024. After combing through the 10-K, the $4B was... More

UnitedHealth Group (UNH) PT Lowered to $405 at JPMorgan, Stays Overweight, ' some of the uncertainty around cost trend should subside.'

May 15, 2025 3:45 AM EDT

JPMorgan analyst Lisa Gill lowered the price target on UnitedHealth Group (NYSE: UNH) to $405.00 (from $525.00) while maintaining a Overweight rating.

The analyst comments "

Following UNH leadership change and suspension of 2025 guidance (see our takeaways here), we are updating our estimates. For a discussion of recent events and our estimate changes, see slides attached. Our 2025 adj. EPS estimate of $22.26 reflects an estimated MLR of 88.6% given the elevated care activity that has worsened in the last month. Looking to 2026e, we assume ~10% y/y adj. EPS growth ($24.58), as we look for progress towards mitigating... More